The OIG audited CMC on 57 outpatient claims for Lupron injections. Lupron is a brand-name drug used to treat prostate cancer, breast cancer and other various conditions. The OIG found all 57 claims were billed incorrectly because the hospital “did not have adequate controls to prevent the incorrect billing” of outpatient Lupron injections for Medicare patients, according to the report.
CMC has refunded the government and said it will improve its Medicare billing compliance.
More Articles on Hospitals and Medicare Overpayments:
Meritus Medical Center Repays $568k to Medicare
OIG: Wing Memorial Hospital Overbilled Medicare $101k for E/M Services
2 Large Kansas Hospitals to Refund Medicare Overpayments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
